Abstract
Background. Kaposi sarcoma (KS)-associated herpesvirus (KSHV) is etiologically linked to all KS forms, but mechanisms underlying KS development are unclear. Te incidence of KS in human immunodefciency virus type 1-infected (HIV-1+) individuals implicates immune dysregulation; however, the lack of characterization of KSHV immune responses in endemic KS makes the role of HIV-1 unclear. Te study objective was to investigate the HIV-1 and KSHV roles in viral nucleic acid detection, antibody responses, and cytokine responses in polymerase chain reaction-confrmed epidemic KS and endemic KS patients and non-cancer controls from sub-Saharan Africa. Methods. KSHV viral DNA (vDNA), total anti-KSHV antibody, KSHV neutralizing antibody (nAb), and cytokines were quantifed. Results. KSHV vDNA was detectable in tumors but variably in plasma and peripheral blood mononuclear cells. Consistent with elevated antibody-associated cytokines (interleukin [IL] 6, IL-5, and IL-10), nAb titers were higher in epidemic KS and endemic KS patients than in controls (P <.05). Despite HIV-1 coinfection in epidemic KS, nAb titers were similar between epidemic KS and endemic KS patients (P = 0.3). Conclusions. Similarities in antibody and cytokine responses between epidemic and endemic KS patients suggest that KSHV drives KS pathogenesis, whereas HIV-1 exacerbates it.
Original language | English (US) |
---|---|
Pages (from-to) | 1318-1328 |
Number of pages | 11 |
Journal | Journal of Infectious Diseases |
Volume | 219 |
Issue number | 8 |
DOIs | |
State | Published - Apr 8 2019 |
Keywords
- Cytokines
- KSHV
- Kaposi sarcoma
- Neutralizing antibody
- Sub-Saharan Africa
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases